Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Bio-Rad and Gencurix
    1 October 2025

    Bio-Rad extends partnership with Gencurix through strategic agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe

    Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using Droplet Digital™ PCR (ddPCR™) for Clinical Testing of Critical Oncology Biomarkers ...

    eg technology promotes Russ Farn to the position of Director
    2 October 2025

    Russ Farn joins eg technology’s Board of Directors

    eg technology is pleased to announce the promotion of Russ Farn to the position of Director.Russ will join the eg technology Board of Directors, where he will contribute to shaping the company’s strategic direction and guiding the oversight of operational planning and project delivery. ...

    CJ & L Consultancy Ltd
    1 October 2025

    CJ & L Consultancy to launch ‘Rent an eQMS’ – A ready-to-use Compliance Solution on 1st November 2025

    Start-ups and small businesses can now access a fully functioning Electronic Quality Management System (eQMS) without the heavy investment of building one in-house. Designed to meet ISO 9001, 13485, 27001, and 45001, our eQMS is adaptable, secure, and available immediately — so you can...

    John Addenbrooke Lecture
    1 October 2025

    Leading Hospital charity in East of England praised for investing early on in promising medical professionals’ careers – helping to bring breakthroughs and change in patient care and treatments  

    Leading hospital charity Addenbrooke's Charitable Trust (ACT) this year celebrates its 30th anniversary - with its supporters donating more than £150 million towards supporting innovation in patient care. One area the charity is able to invest in is research and fellowships - investing ...

    Dr Yang Wang (left) and Dr Peter Rugg-Gunn (right) shown over a data analysis plot from the scMTR-seq technique (Wang et al. 2025. Figure 3, E - Clustered smooth heatmaps showing gene expression and associated histone modification levels at their promoters and gene bodies).
    30 September 2025

    Prizes for team behind game-changing multi-omics method to decode gene regulation

    Babraham Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and gene expression in single cells. Lead researchers, Peter Rugg-Gunn and Yang Wang, received the Top Rising Star award by BioCentury Grand Rounds in recognit...

    Dr Robert Neely CSO and Co-Founder,  Tagomics
    30 September 2025

    Tagomics publishes a new approach to genome-wide epigenomic profiling

    Study published in ‘Cell Reports Methods’ demonstrates the strength of Tagomics’ platform for epigenomic biomarker discovery and applications in liquid biopsyActivace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epig...

     Oxford Med-Tech Fair
    29 September 2025

    Building bridges at the Oxford Med-Tech Fair: EFEC’s UK–China life sciences vision

    EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners. ...

    Elliott
    29 September 2025

    Guardtech support staff member’s epic trek for cancer charity close to the business’ heart

    The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel ...

    Miebach’s new facilities at Abingdon Science Park, Oxford	Miebach’s new facilities at Abingdon Science Park, Oxford
    26 September 2025

    Miebach Consulting doubles footprint on Abingdon Science Park

    Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth ...

    fibroblast single cell
    25 September 2025

    Universal drug target potential in scaffolding cells found across the body

    Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 52
    • Page 53
    • Current page 54
    • Page 55
    • Page 56
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS